Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 7:dgaf265.
doi: 10.1210/clinem/dgaf265. Online ahead of print.

Real-world Glycemic and Person-Reported Outcomes after Tandem Control-IQ initiation in Children with Type 1 Diabetes

Jolien De Meulemeester  1 , Laura Valgaerts  1 , Guy Massa  2 , Inge Gies  3 , Sylvia Depoorter  4 , Sara Vanaken  5 , Olimpia Chivu  6 , Marieke den Brinker  7 , Thierry Mouraux  8 , Marlies Vanloocke  9 , Marie-Christine Lebrethon  10 , Anissa Messaaoui  11 , Philippe Lysy  12 , Lut Dooms  13 , Chantal Mathieu  1 , Kristina Casteels  14 , Pieter Gillard  1
Affiliations

Real-world Glycemic and Person-Reported Outcomes after Tandem Control-IQ initiation in Children with Type 1 Diabetes

Jolien De Meulemeester et al. J Clin Endocrinol Metab. .

Abstract

Aims: This multicenter prospective observational cohort study assessed real-world changes in glycemic and person-reported outcomes one-year after Control-IQ initiation in children and adolescents with type 1 diabetes.

Methods: Between October 2021 and December 2022, all children 6-18 years who started Control-IQ at 13 Belgian centers were consecutively recruited. Data were collected at start of Control-IQ and after 4, 8 and 12 months. Person-reported outcomes were evaluated through questionnaires (Diabetes Quality of Life for Youth [DQOLY], Hypoglycemia Fear Survey [HFS], HAPPI-D). Data are reported as mean ± SD or least-squares mean (95% CI).

Results: A total of 114 children were included, with a mean age of 12.0 ± 3.2 years and of whom 61.4% were girls. Time in range (3.9-10.0 mmol/L) increased from start (51.6% [47.6-55.5]) to 12 months (64.4% [61.2-67.5]) (p<0.001). After 12 months, HbA1c decreased from 62 mmol/mol (60-65) (7.8% [7.6-8.1]) to 54 mmol/mol (52-56) (7.1% [6.9-7.3]) and time <3.9 mmol/L from 3.9% (3.1-4.8) to 2.7% (1.9-3.5) (all p<0.001). Children scored better on DQOLY satisfaction (70.4 [67.8-73.0] vs 74.0 points [71.3-76.6]) and DQOLY impact (54.6 [50.9-58.3] vs 51.3 points [47.4-55.1]), and parents on HAPPI-D (22.5 [21.1-23.9] vs 19.6 points [18.2-21.0]) and HFS worry (25.0 [21.6-28.4] vs 20.3 points [17.0-23.5] (all p<0.001). Children missed fewer days of school (287 vs 30 days/100 person-years, p=0.001) and parents missed less days of work (247 vs 47 days/100 person-years, p<0.001).

Conclusions: One-year use of Control-IQ was associated with improved glycemic management, more diabetes-related quality of life and fewer school/work absences.

Keywords: Children and adolescents; Control-IQ technology; Hybrid closed-loop; Type 1 diabetes; automated insulin delivery; t:slim X2.

PubMed Disclaimer